Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.
about
Clinical and laboratory prognostic indicators in chronic lymphocytic leukemiaCharacterization of CD200 Ectodomain SheddingExploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton.Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathThe absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOPRelationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study.Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.Bio-activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells.Evaluation of Prognostic Impact of Soluble CD14 in B-Chronic Lymphocytic Leukemia.Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.Ingested soluble CD14 from milk is transferred intact into the blood of newborn rats.Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.Interaction between myelomonocytic and lymphoid cells in a patient with acute myelomonocytic leukemia and chronic lymphocytic leukemia.Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.CD14-159C/T polymorphism in the development of delayed skin hypersensitivity to tuberculin.Extracellular vesicles in chronic lymphocytic leukemia.TNF receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
P2860
Q26830323-5CF060F7-F613-448A-A4AA-0CD18BB64569Q28551557-9380A071-9E88-4352-929E-28F96A2BA522Q34056568-810B71F9-8F05-4E4C-9B17-3B2B556A73DFQ35054626-4295E529-FF1C-47BA-AB18-06DBA8DDC3B8Q35569491-CC645E6C-C02A-440E-BF53-2CB4AC55C3DEQ35930211-35C47836-78AD-4830-9227-361631C8941CQ36216519-B85B2BF7-C026-4C16-8CC1-6652D6E4652AQ37472823-355C883F-95A2-457B-B33E-6C4BEA4B26BBQ38550810-345C7C31-A244-4ED3-9D4F-207EC6F779E6Q38966197-C856B419-CC1E-4F8E-9538-46E1974CB9B6Q39052314-107623A6-7F0D-4824-B1FB-48885CC8E72FQ39201525-478662D1-9C0D-4588-9989-843177B01E0DQ39327432-ADA6A1C1-309D-4E19-B5BB-AE949320135EQ40369611-A3F5CF1C-C91B-4E2D-8D8C-541EE4503918Q40928223-D0F071EF-C775-45B4-9316-E2372EDA8B07Q42395937-D38D971C-7AC4-477D-9F46-5EDC61874F46Q42638970-E3532D10-BB6E-463E-AEA6-EFFA57606A34Q42917701-227F8F7C-C0C5-4F2F-9EB2-80EE8B73E2A8Q43813493-92F94209-668C-4722-B590-E75D95692021Q46325508-3952008B-CFE4-43AE-B256-C423D380582FQ47187631-F59D53BF-4459-4E38-B809-C9560C623FFAQ48019939-78AA1B9C-6754-49CB-94D6-37875B4A7410Q50078371-56BF1DA7-6BAF-417A-B444-2C7F1E089AB6Q52323624-894D0DBA-7451-4073-9895-D4228A2C38A9Q53088774-8C9A41A8-568D-4339-B546-8F31694877B7Q53153100-8B40A2D6-FF94-4166-9A74-927115249D6F
P2860
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@en
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@nl
type
label
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@en
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@nl
prefLabel
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@en
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@nl
P2093
P50
P1433
P1476
Soluble CD14 is a novel monocy ...... bnormally high levels in vivo.
@en
P2093
Angela Schulz
Martina Seiffert
Sibylle Ohl
P304
P356
10.1182/BLOOD-2010-05-284505
P407
P577
2010-07-26T00:00:00Z